Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Akio Inui
The field of drug development is continually evolving to ensure the efficacy and safety of new medications. Traditionally, toxicology focused on animal testing to assess potential drug toxicity, but this approach has limitations in predicting human responses accurately. In recent years, systems toxicology methods have emerged, incorporating systems biology, omics technologies, and computational modeling to provide a comprehensive understanding of druginduced toxicity at various biological levels. This article explores the concept of systems toxicology and its contributions to enhancing drug safety. By analyzing drug responses from genes to tissues and organs, systems toxicology offers mechanistic insights and facilitates the early identification of potential toxicity during drug development. Furthermore, it reduces the reliance on animal testing, supports personalized medicine approaches, and empowers risk assessment strategies. Despite challenges, advancements in computational tools and collaboration among stakeholders pave the way for safer medications and a more effective drug development process in the future.